The BCN-Bio-HF prediction model (14) enhanced predictive performance by incorporating three emerging biomarkers—BNP, high-sensitivity cardiac troponin T (hs-cTnT), and soluble toll-like receptor-2 (ST2)—in addition to conventional predictors. This evidence concerns the gene TLR2 and hydrops fetalis.